Laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006
Revises EU rules on the authorisation and supervision of medicinal products and updates the framework for the European Medicines Agency.
Latest movement
The file was sent to a parliamentary committee
Current stage updated
EP 2nd Reading
Where this file is now
An ordinary EU law can be agreed at first reading. Second reading and conciliation are only needed if agreement has not been reached. EUvahti marks the current recorded step; the other steps below are possible stages, not confirmed events for this file.
- Commission Proposal26 Apr 2023
- EP Committee
- EP 1st Reading
- Council Position
- EP 2nd Reading · If needed · Current recorded stepLast dated movement: 8 Oct 2026
- Conciliation · If needed
- Adopted
- Published in OJ
EP 2nd Reading
Parliament is examining the Council position at second reading.
Show the complete Parliament activity record
Official documents
EP report ENVI-PR-753550
EP report - 20 Oct 2023
Committee opinion AGRI-AL-757314
Committee opinion - 24 Jan 2024
Committee opinion BUDG-AL-759054
Committee opinion - 14 Feb 2024
Committee opinion ITRE-AD-754772
Committee opinion - 22 Feb 2024
EP resolution TA-9-2024-0221
EP resolution - 10 Apr 2024
Provisional agreement SANT-AG-792227
Provisional agreement - 18 Mar 2026